PolyPid Ltd. (PYPD) |
| 5.29 0.04 (0.76%) 10-26 16:00 |
| Open: | 5.3 |
| High: | 5.365 |
| Low: | 5.17 |
| Volume: | 93,977 |
| Market Cap: | 107(M) |
| PE Ratio: | -3.57 |
| Exchange: | NASDAQ Global Market |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 6.48 |
| Resistance 1: | 5.55 |
| Pivot price: | 5.01 |
| Support 1: | 4.97 |
| Support 2: | 4.61 |
| 52w High: | 5.73 |
| 52w Low: | 3.402 |
PolyPid Ltd. is an advanced-stage biopharmaceutical company specializing in the development, manufacturing, and commercialization of therapeutic solutions. These solutions are based on its proprietary polymer-lipid encapsulation matrix (PLEX) platform, with the goal of addressing significant unmet medical needs. The company's leading product candidate, D-PLEX100, is currently undergoing Phase III clinical trials. It is being evaluated for its efficacy in preventing surgical site infections (SSIs) following both sternal (bone) and abdominal (soft tissue) procedures. Established in 2008, PolyPid Ltd. is headquartered in Petah Tikva, Israel.
Financials
| EPS | -1.440 |
| Book Value | 0.260 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | -74.6 |
| Return on Equity (ttm) | -243.6 |
Company news
Fri, 23 Oct 2026
PolyPid Ltd. Estimates – NASDAQ:PYPD - TradingView
Thu, 15 Oct 2026
A new candidate for diabetic foot infections will be introduced at PolyPid's Oct. 28 investor event. - Stock Titan
Fri, 09 Oct 2026
PolyPid Ltd. (PYPD) Gets EMA MAA Validation, Reclaims EU Rights for D-PLEX100 - TradingView
Wed, 12 Aug 2026
PolyPid Ltd (PYPD) (Q2 2026) Earnings Call Highlights: FDA Priority Review and $30M Azurity ... - Yahoo Finance
Tue, 21 Jul 2026
PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada - Yahoo Finance
Sat, 27 Jun 2026
PYPD Forecast — Price Target — Prediction for 2027 - TradingView
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
